Junshi Biosciences has received acceptance from China’sNational Medical Products Administration (NMPA) for toripalimab ...

This episode, titled Optimizing Subcutaneous Therapies in NSCLC: Practical Integration, Patient Selection, and Workflow ...

The melanocortin 4 receptor agonist setmelanotide is now FDA approved for weight management in adults and children with ...

Officials with the FDA have approvedthe first generic robenacoxib injectable (Robenacoxib Injection; Cronus Pharma Specialties) for the control of postoperative pain and inflammation in canine and ...

Forlong Biotechnology, a clinical-stage biotech company focusing on developing transformative cytokine therapies for patients with severe unmet needs, today announced that preclinical data from its IL ...

Three experimental injectable antiretrovirals – a novel capsid inhibitor and two next-generation integrase inhibitors – could ...

LEO Pharma A/S, a global leader in medical dermatology, today announced it will present 17 scientific posters at the 2026 American Academy of Dermatology (AAD) Annual Meeting (March 27-31, Denver, ...

KT501 is engineered to target a broad spectrum of B-cell populations, including plasma cells, by simultaneously binding to CD19 and BCMA. Unlike traditional B-cell therapies, KT501 is designed to ...

Rani Therapeutics will host a conference call and live webcast at 4:30 p.m. ET / 1:30 p.m. PT on March 26, 2026. Individuals interested in listening to the live conference call may do so by using the ...

Phase 3 data show lebrikizumab improves skin clearance and itch in children with moderate to severe atopic dermatitis, ...

According to Maximize Market Research, the Global Heparin Market is projected to reach USD 8.7 billion in 2025 and is expected to grow at a CAGR of 4.57% from 2026 to 2032. The market is witnessing ...

Povetacicept significantly reduced proteinuria in patients with IgA nephropathy in the RAINIER trial, supporting an upcoming FDA submission.